Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1812
  • Home
  • Print this page
  • Email this page
CURRENT OPHTHALMOLOGY
Year : 1996  |  Volume : 44  |  Issue : 2  |  Page : 69-76

Neuronal basis of amblyopia: A review


1 Department of Clinical Ophthalmology and Save Sight Institute, University of Sydney, Australia
2 Department of Ophthalmology, Christian Medical College, Schell Eye Hospital, Vellore, India

Correspondence Address:
John Grigg
Department of Clinical Ophthalmology and Save Sight Institute, University of Sydney P.O.Box 493 Darlinghurst, NSW 2010, Australia
Australia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 8916592

Rights and PermissionsRights and Permissions

Amblyopia is an acquired defect in vision due to an abnormal visual experience during a sensitive period of visual development. The neuronal basis of amblyopia is the study of the effects of "abnormal" environmental influences on the genetically programmed development of the visual processing system. Visual pathway development commences with ganglion cells forming the optic nerve. The process that guides these neurones initially to the lateral geniculate nucleus (LGN) and then onto the visual cortex is genetically programmed. Initially this process is influenced by spontaneously generated impulses and neurotrophic factors. Following birth, visual stimuli modify and refine the genetically programmed process. Exposure to the visual environment includes the risk of abnormal inputs. Abnormal stimuli disrupt the formation of patterned inputs allowing alteration of visual cortical wiring with reduction in ocular dominance columns driven by the abnormal eye. Correction of the abnormal visual input and penalisation of the "normal" input is the mainstay of therapy for amblyopia. Further understanding of the mechanisms involved in the development of a normal visual processing system will allow trialing therapies for amblyopia not responding to occlusion therapy. Levodopa is one agent providing insights into recovery of visual function for short periods in apparently mature visual systems.


[FULL TEXT] [PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed18334    
    Printed314    
    Emailed16    
    PDF Downloaded1    
    Comments [Add]    

Recommend this journal